Australia
# |
Name |
EBITDA |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 4.73 B
|
June 30, 2024 | USD 173.13 | 0.11% |
|
Australia |
|
2 |
USD 396.68 M
|
June 30, 2024 | USD 20.43 | 1.47% |
|
Australia |
|
3 |
USD 202.30 M
|
June 30, 2024 | USD 21.11 | 1.40% |
|
Australia |
|
4 |
USD 113.12 M
|
June 30, 2024 | USD 2.14 | 0.82% |
|
Australia |
|
5 |
USD 80.52 M
|
June 30, 2024 | USD 157.25 | 0.24% |
|
Australia |
|
6 |
USD 37.52 M
|
June 30, 2024 | USD 7.32 | 6.16% |
|
Australia |
|
7 |
USD 34.97 M
|
Jan. 31, 2024 | USD 1.81 | -0.44% |
|
Australia |
|
8 |
USD 15.64 M
|
Dec. 31, 2023 | USD 15.47 | 4.25% |
|
Australia |
|
9 |
USD 3.45 M
|
June 30, 2024 | USD 1.33 | 6.17% |
|
Australia |
|
10 |
USD -2.07 M
|
Dec. 31, 2023 | USD 1.27 | -1.68% |
|
Australia |
|
11 |
USD -4.59 M
|
June 30, 2024 | USD 2.00 | 1.52% |
|
Australia |
|
12 |
USD -13.05 M
|
June 30, 2024 | USD 3.31 | -4.06% |
|
Australia |
|
13 |
USD -13.57 M
|
June 30, 2024 | USD 0.62 | -2.68% |
|
Australia |
|
14 |
USD -17.85 M
|
June 30, 2024 | USD 1.53 | 1.32% |
|
Australia |
|
15 |
USD -18.50 M
|
June 30, 2024 | USD 1.77 | -1.67% |
|
Australia |
|
16 |
USD -25.42 M
|
June 30, 2024 | USD 0.74 | -1.40% |
|
Australia |
|
17 |
USD -29.70 M
|
June 30, 2024 | USD 1.93 | -0.52% |
|
Australia |
|
18 |
USD -29.77 M
|
June 30, 2024 | USD 2.37 | 1.84% |
|
Australia |
|
19 |
USD -45.56 M
|
Dec. 31, 2023 | USD 5.88 | 0.14% |
|
Australia |
|
20 |
USD -56.08 M
|
June 30, 2024 | USD 1.58 | -2.06% |
|
Australia |
|
21 |
USD -77.96 M
|
June 30, 2024 | USD 2.80 | 2.04% |
|
Australia |
|
22 |
USD -200.02 M
|
June 30, 2024 | USD 3.82 | 6.70% |
|
Australia |
The Pharmaceuticals company in Australia with the highest EBITDA is CSL Limited (ASX: CSL.AX) at USD 4.73 B.
The Pharmaceuticals company in Australia with the lowest EBITDA is Opthea Limited (NasdaqGS: OPT) at USD -200.02 M.
The top 10 Pharmaceuticals companies in Australia by EBITDA are CSL Limited, EBOS Group Limited, Ansell Limited, Australian Clinical Labs Limited, Pro Medicus Limited, Clinuvel Pharmaceuticals Limited, Sigma Healthcare Limited, Telix Pharmaceuticals Limited, PolyNovo Limited and Cyclopharm Limited.
The bottom 10 Pharmaceuticals companies in Australia by EBITDA are Opthea Limited, Mayne Pharma Group Limited, Mesoblast Limited, Anteris Technologies Ltd, Clarity Pharmaceuticals Ltd, Immutep Limited, PYC Therapeutics Limited, Incannex Healthcare Limited, Kazia Therapeutics Limited and Trajan Group Holdings Limited.